Dementia Drugs Under Scrutiny: New Research Reveals Risks

Dementia impacts approximately 55 million people worldwide, contributing to an estimated 10 million new cases each year and standing as a primary global cause of death. Lead author Dr. Catherine Sinnamon noted that while antidepressants are common, they may not always be suitable for dementia patients.

The study's principal investigator, Dr. Heather Barry, stated that the research findings deepen understanding and underscore the necessity of prescribing medications judiciously for individuals with dementia. This emphasizes the importance of consistent and comprehensive medication reviews by healthcare professionals, such as GPs or pharmacists.